Cybin is listed on the NASDAQ stock exchange, receiving buy rating coverage from TD Cowen, while Millennium Management increased its stake.

The entities involved

• Cybin →

  Canadian pharmaceutical company

  Nothing else this week.

• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36

Related events

• TD Cowen upgraded Crescent Biopharma shares to 'strong-buy', while Wedbush reiterated 'outperform', and a CEO sold shares under a 10b5-1 plan.Aug 27
• Lakefront Biotherapeutics (LKFT) is trading on Nasdaq as various financial firms issue rating updates, including a buy rating from TD Cowen and price target cuts from Morgan Stanley and RBC.Sep 17
• TD Cowen, Stephens, Citigroup, and MarketBeat provided new analyst ratings and coverage for Covenant Logistics Group, Inc.Jul 18
• Two small-cap healthcare companies, Cardiff Oncology and CytomX Therapeutics, are listed on NASDAQ and receive analyst recommendations from MarketBeat.Sep 11
• EyePoint Pharmaceuticals was listed on Nasdaq, accompanied by rating updates from TD Cowen (downgrade) and Jefferies (upgrade).Mon 06:52